FDA Dropping Black Box Warning on Hormone Replacement Therapy

“We’re challenging outdated thinking and recommitting to evidence-based medicine that empowers rather than restricts,” the health secretary said.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

Federal officials are removing a warning from treatments for menopause symptoms, they announced on Nov. 10.

Hormone replacement therapy, or estrogen treatments, will no longer warn women that taking the treatments can raise the risk of cardiovascular disease, breast cancer, and probable dementia, the Department of Health and Human Services (HHS), the parent agency of the Food and Drug Administration, said in a statement.